Statistics

Total Visits

Views
Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: Final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial64

Select a period of time:

Number of views in the range

Views
Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: Final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial15

Views

Views
June 20253
July 20257
August 20250
September 20250
October 20250
November 20255
December 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil6
Singapore3
United States2
Argentina1
Ethiopia1
United Kingdom1
Peru1
 

Top cities views

Views
Chicago1
Formiga1
Laferrere1
Lima1
Londrina1
Passo Fundo1
Paulo Afonso1
São José de Ribamar1
São José do Rio Preto1